PET/CT in evaluating pediatric malignancies: A clinician's perspective

Journal of Nuclear Medicine

Volumn 48, Issue 12, 2007, Pages 1920-1922

  Federman, Noah ^a   Feig, Stephen A ^a  

^a MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; FLUORODEOXYGLUCOSE; MEDRONATE TECHNETIUM TC 99M;

CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHILD CARE; CLINICAL PRACTICE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE COURSE; FOLLOW UP; HODGKIN DISEASE; HUMAN; NEUROFIBROMATOSIS; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RECURRENT CANCER; REVIEW; SARCOMA;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 36849085824     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.046045     Document Type: Review

References (20)

1. Czernin J, Allen-Auerbach M, Schelbert HR. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. J Nucl Med. 2007;48(suppl):78S-88S.
2. Czernin J, Schelbert HR. PET/CT imaging: facts, opinions, hopes, and questions. J Nucl Med. 2004; 45(suppl):1S-3S.
3. 18F-FDG PET/ CT in evaluating non-CNS pediatric malignancies. J Nucl Med. 2007;48:1923-1931.
4. Rhodes MM, Delbeke D, Whitlock JA, et al. Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma. J Pediatr Hematol Oncol. 2006;28:300-306.
5. 18F-FDG PET/CT in staging and follow-up of lymphoma in pediatric and young adult patients. J Comput Assist Tomogr. 2006;30:689-694.
6. Hudson MM, Donaldson SS. Treatment of pediatric Hodgkin's lymphoma. Semin Hematol. 1999;36:313-323.
7. NCT00025259. National Institutes of Health Children's Oncology Group AHOD0031. Available at: www.cancer.gov/clinicaltrials/COG-AHOD0031. Accessed October 19, 2007.
8. Arush MW, Israel O, Postovsky S, et al. Positron emission tomography/computed tomography with 18-fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma. Pediatr Blood Cancer. January 24, 2007 [Epub ahead of print].
9. Iagaru A, Quon A, McDougall IR. F-18 FDG-PET/ CT evaluation in osseous and soft tissue sarcomas. Clin Nucl Med. 2006;31:754-760.
10. McCarville MB, Christie R, Daw NC. PET/CT in the evaluation of childhood sarcomas. AJR. 2005; 184:1293-1304.
11. Otsuka H, Graham MM, Kubo A, Nishitani H. FDG-PET/CT findings of sarcomatous transformation in neurofibromatosis: a case report. Ann Nucl Med. 2005;19:55-58.
12. Pierce DA, Shimizu Y, Preston DL, et al. Studies of the mortality of atomic bomb survivors: Report 12, Part 1 - Cancer: 1950-1990. Radiat Res. 1996; 146:1-27.
13. Brenner DJ, Elliston CD, Hall EJ, et al. Estimating cancer risks from pediatric CT: going from the qualitative to the quantitative. Pediatr Radiol. 2002;32:228-231.
14. Slovis TL. Conference on the ALARA (as low as reasonably achievable) concept in pediatric CT: intelligent dose reduction. Pediatr Radiol. 2002;32:217-218.
15. 18F-FDG PET/CT examinations. J Nucl Med. 2005; 46:608-613.
16. Frush DP, Donnelly LF, Rosen NS. Computed tomography and radiation risks: what pediatric health care providers should know. Pediatrics. 2003;112:951-957.
17. 18F-FDG PET/CT in pediatric oncology [abstract]. J Nucl Med. 2007;48(suppl 2):118P.
18. Franzius C, Daldrup-Link HE, Sciuk J, et al. FDG-PET for the detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol. 2001;12:479-486.
19. Sanborn PA, Michna E, Zurakowski D, et al. Adverse cardiovascular and respiratory events during sedation of pediatric patients for imaging examinations. Radiology. 2005;237:288-294.
20. Franzius C, Schober O. Is PET/CT necessary in paediatric oncology? Eur J Nucl Med Mol Imaging. 2006;33:960-965.